<?xml version="1.0" encoding="UTF-8"?>
<ref id="B211-viruses-11-01017">
 <label>211.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hosoya</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Mori</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Tomoda</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Mori</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Sawaishi</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kimura</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Shigeta</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Suzuki</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Pharmacokinetics and Effects of Ribavirin Following Intraventricular Administration for Treatment of Subacute Sclerosing Panencephalitis</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2004</year>
  <volume>48</volume>
  <fpage>4631</fpage>
  <lpage>4635</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.48.12.4631-4635.2004</pub-id>
  <pub-id pub-id-type="pmid">15561836</pub-id>
 </element-citation>
</ref>
